Seer is a finalist in the 2018 Telstra Business Awards!

Seer is one of only 84 finalists in the 2018 Telstra Business Awards. 

The prestigious program recognises the best in business across four categories: Emerging and Energised, Small and Succeeding, Medium and Making Waves, and Social Change Maker.

Seer, one of over 10,000 entries in this years awards, was evaluated across a broad range of criteria, including: strategy and vision, customers and marketing, operations, people and culture, innovation and technology, social responsibility and financial acumen.

State winners will be announced at a celebratory dinner in August, with National winners announced in September. 

Wish us luck! 

You can read more about the awards and the other finalists here

Breakthrough epilepsy monitoring device receives investment funding

Seer Medical's Mark Cook, in conjunction with The Bionics Institute, St Vincent's Melbourne and the University of Melbourne has launched a new Australian venture to develop a breakthrough monitoring device to improve management of epilepsy and seizure-related conditions – Minder ™.

The successful venture with an initial A$3.65 million investment from Cochlear Ltd and other Australian investors is a culmination of a decade of research and development into improving outcomes for Epilepsy sufferers and has been led by Seer Director, Prof Mark Cook and A/Prof Chris Williams from the Bionics Institute.

Read more about the device on the Bionics Institute website here.  

Seer Medical assist epilepsy trial in Tasmania

Seer Medical conducted at-home monitoring for people with severe epilepsy taking part in a trial for medicinal cannabis to reduce their seizure rates